Toxoplasma gondii is an intracellular protozoan parasite capable of causing chronic infection by forming persistent cysts in the brain. Despite its global burden, no approved vaccine exists. Virus-like particle vaccines expressing microneme protein 8 (MIC8) or apical membrane antigen 1 (AMA1) of T. gondii have previously shown efficacy. In this study, we generated recombinant vaccinia viruses (rVVs) expressing MIC8 and AMA1 and evaluated their efficacy against T. gondii ME49 infection. BALB/c mice were intramuscularly immunized with a combination of MIC8 and AMA1 rVVs and challenged orally with T. gondii ME49. Immunization with MIC8+AMA1 rVVs produced a significant increase in T. gondii-specific IgG. Splenocyte analysis revealed robust activation of CD4+ and CD8+ T cells, as well as expansion of memory B cells. The immunized group exhibited an 89.6% reduction in brain cyst count, with significantly improved survival compared to the control group. These findings demonstrate that combining the antigens MIC8 and AMA1 using a vaccinia virus platform can effectively promote both humoral and cellular immunity, supporting its potential as a vaccine strategy against T. gondii ME49.
Citations
Citations to this article as recorded by
Protection Against Toxoplasma gondii Lethal ME49 Challenge Induced by Influenza Virus-like Particles Containing Dense Granule Protein 14 Jie Mao, Hae-Ji Kang, Gi-Deok Eom, Su In Heo, Hynnu Nam, Ji-Hyun Lee, Ki-Ho Park, Mi Suk Lee, Sung Soo Kim, Fu-Shi Quan Pharmaceutics.2026; 18(1): 93. CrossRef
Malaria is a global disease affecting a large portion of the world’s population. Although vaccines have recently become available, their efficacies are suboptimal. We generated virus-like particles (VLPs) that expressed either apical membrane antigen 1 (AMA1) or microneme-associated antigen (MIC) of Plasmodium berghei and compared their efficacy in BALB/c mice. We found that immune sera acquired from AMA1 VLP- or MIC VLP-immunized mice specifically interacted with the antigen of choice and the whole P. berghei lysate antigen, indicating that the antibodies were highly parasite-specific. Both VLP vaccines significantly enhanced germinal center B cell frequencies in the inguinal lymph nodes of mice compared with the control, but only the mice that received MIC VLPs showed significantly enhanced CD4+ T cell responses in the blood following P. berghei challenge infection. AMA1 and MIC VLPs significantly suppressed TNF-α and interleukin-10 production but had a negligible effect on interferon-γ. Both VLPs prevented excessive parasitemia buildup in immunized mice, although parasite burden reduction induced by MIC VLPs was slightly more effective than that induced by AMA1. Both VLPs were equally effective at preventing body weight loss. Our findings demonstrated that the MIC VLP was an effective inducer of protection against murine experimental malaria and should be the focus of further development.
Citations
Citations to this article as recorded by
Orally Dissolving Film-Based Influenza Vaccines Confer Superior Protection Compared to the Oral Administration of Inactivated Influenza Virus Keon-Woong Yoon, Jie Mao, Gi-Deok Eom, Su In Heo, Ki Back Chu, Mi Suk Lee, Fu-Shi Quan Vaccines.2025; 13(6): 600. CrossRef
Protective Efficacy Induced by Virus-like Particles Expressing Dense Granule Protein 5 of Toxoplasma gondii Su In Heo, Hae-Ji Kang, Jie Mao, Zhao-Shou Yang, Md Atique Ahmed, Fu-Shi Quan Vaccines.2025; 13(8): 787. CrossRef
Efficacy of Heterologous Vaccination Using Virus-Like Particles and Vaccinia Virus Containing MIC8 and AMA1 Proteins of Toxoplasma gondii Hae-Ji Kang, Fu-Shi Quan Vaccines.2025; 13(8): 862. CrossRef
Ivermectin Identified Using a High-Throughput Screening System Exhibits Anti-Clonorchis sinensis Activity in Rats Soon-Ok Lee, Hyeryon Lee, Ki Back Chu, Jianhua Li, Sung-Jong Hong, Sung Soo Kim, Joo Hwan No, Fu-Shi Quan Antibiotics.2025; 14(8): 837. CrossRef
Toxoplasma gondii infections are primarily diagnosed by serological assays, whereas molecular and fluorescence-based techniques are garnering attention for their high sensitivity in detecting these infections. Nevertheless, each detection method has its limitations. The toxoplasmosis detection capabilities of most of the currently available methods have not been evaluated under identical experimental conditions. This study aimed to assess the diagnostic potential of enzyme-linked immunosorbent assay (ELISA), real-time polymerase chain reaction (RT-PCR), immunohistochemistry (IHC), and immunofluorescence (IF) in BALB/c mice experimentally infected with various doses of T. gondii ME49. The detection of toxoplasmosis from sera and brain tissues was markedly enhanced in mice subjected to high infection doses (200 and 300 cysts) compared to those subjected to lower doses (10 and 50 cysts) for all the detection methods. Additionally, increased B1 gene expression levels and cyst sizes were observed in the brain tissues of the mice. Importantly, IHC, IF, and ELISA, but not RT-PCR, successfully detected T. gondii infections at the lowest infection dose (10 cysts) in the brain. These findings may prove beneficial while designing experimental methodologies for detecting T. gondii infections in mice.
Citations
Citations to this article as recorded by
Protection Against Toxoplasma gondii Lethal ME49 Challenge Induced by Influenza Virus-like Particles Containing Dense Granule Protein 14 Jie Mao, Hae-Ji Kang, Gi-Deok Eom, Su In Heo, Hynnu Nam, Ji-Hyun Lee, Ki-Ho Park, Mi Suk Lee, Sung Soo Kim, Fu-Shi Quan Pharmaceutics.2026; 18(1): 93. CrossRef
Spatiotemporal Diffusion, Colonization, and Antibody Responses in Susceptible C57BL/6J Mice Orally Infected with Toxoplasma gondii Cysts Zhao Li, Qi-Shuai Liu, Jun-Jie Hu, Cai-Qin Deng, Tao Li, Wen-Bin Zheng, Xing-Quan Zhu, Feng-Cai Zou Veterinary Sciences.2025; 12(3): 212. CrossRef
Ivermectin Identified Using a High-Throughput Screening System Exhibits Anti-Clonorchis sinensis Activity in Rats Soon-Ok Lee, Hyeryon Lee, Ki Back Chu, Jianhua Li, Sung-Jong Hong, Sung Soo Kim, Joo Hwan No, Fu-Shi Quan Antibiotics.2025; 14(8): 837. CrossRef
Recombinant vaccinia virus expressing MIC8, AMA1, or RON4 induce protection against Toxoplasma gondii ME49 strain infection Hae-Ji Kang, Fu-Shi Quan Acta Tropica.2025; 270: 107812. CrossRef
Protective Efficacy Induced by Virus-like Particles Expressing Dense Granule Protein 5 of Toxoplasma gondii Su In Heo, Hae-Ji Kang, Jie Mao, Zhao-Shou Yang, Md Atique Ahmed, Fu-Shi Quan Vaccines.2025; 13(8): 787. CrossRef
Vaccinia virus expressing MIC8 and AMA1 provides protection against Toxoplasma gondii ME49 infection Hae-Ji Kang, Yan Jin, Zhao-Shou Yang, Md Atique Ahmed, Fu-Shi Quan Parasites, Hosts and Diseases.2025; 63(4): 340. CrossRef
Toxoplasma gondii ME49 infections are typically diagnosed by serological tests. However, serological diagnosis of RH strain-induced toxoplasmosis remains unknown. In order to develop seradiagnosis of above 2 kinds of infections, we generated recombinant virus-like particles (VLPs) displaying the T. gondii rhoptry protein 4 (ROP4) and evaluated their potential in T. gondii ME49 or RH strain infection diagnostics. Mice were orally infected with either the tachyzoites of T. gondii (RH) or cysts of T. gondii (ME49) at various dosages, and sera were collected at regular intervals. ELISA-based serological tests were performed to assess IgG, IgM, and IgA antibody responses against ROP4 VLP antigen and tissue lysate antigen (TLA). Compared to TLA, IgG, IgM, and IgA levels to ROP4 VLP antigen were significantly higher in the sera of T. gondii RH-infected mice 1 and 2 week post-infection (PI). T. gondii-specific IgG antibody was detected at 1, 2, 4, and 8 week PI in the T. gondii ME49-infected mice with infection dose-dependent manner. These results indicated that the ROP4 VLP antigen was highly sensitive antigens detecting T. gondii RH and ME49 antibodies at an early stage.
Citations
Citations to this article as recorded by
IgM Antibody Detection as a Diagnostic Marker for Acute Toxoplasmosis: Current Status of Studies and Main Limitations Karolina Sołowińska, Lucyna Holec-Gąsior Antibodies.2025; 14(2): 44. CrossRef
Could metformin modulate the outcome of chronic murine toxoplasmosis? Maha Mohamed Gomaa, Samar Nabil El Achy, Nehal Nassef Hezema Acta Tropica.2024; 258: 107339. CrossRef
Trend in serological and molecular diagnostic methods for Toxoplasma gondii infection Min-ju Kim, Soeun J. Park, Hyunwoo Park European Journal of Medical Research.2024;[Epub] CrossRef
Recombinant AMA1 Virus-like Particle Antigen for Serodiagnosis of Toxoplasma gondii Infection Min-Ju Kim, Ki-Back Chu, Jie Mao, Hae-Ji Kang, Gi-Deok Eom, Keon-Woong Yoon, Su-Hwa Lee, Eun-Kyung Moon, Young-Ha Lee, Fu-Shi Quan Biomedicines.2022; 10(11): 2812. CrossRef
Toxoplasmagondii can infect humans worldwide, causing serious diseases in pregnant women and immunocompromised individuals. T. gondii rhoptry protein 13 (ROP13) is known as one of the key proteins involved in host cell invasion. In this study, we generated virus-like particles (VLPs) vaccine expressing T. gondii rhoptry ROP13 and investigated VLPs vaccine efficacy in mice. Mice immunized with ROP13 VLPs vaccine elicited significantly higher levels of T. gondii-specific IgG, IgG1, IgG2a, and IgA antibody responses following boost immunization and challenge infection, whereas antibody inductions were insignificant upon prime immunization. Differing immunization routes resulted in differing antibody induction, as intranasal immunization (IN) induced greater antibody responses than intramuscular immunization (IM) after boost and challenge infection. IN immunization induced significantly higher levels of IgG and IgA antibody responses from feces, antibody-secreting cells (ASCs), CD4+ T, CD8+ T cells and germinal center B cell responses in the spleen compared to IM immunization. Compared to IM immunization, IN immunization resulted in significantly reduced cyst counts in the brain as well as lesser body weight loss, which contributed to better protection. All of the mice immunized through either route survived, whereas all na?ve control mice perished. These results indicate that the ROP13 VLPs vaccine could be a potential vaccine candidate against T. gondii infection.
Citations
Citations to this article as recorded by
A state-of-the-art methodology for high-throughput in silico vaccine discovery against protozoan parasites and exemplified with discovered candidates for Toxoplasma gondii Stephen J. Goodswen, Paul J. Kennedy, John T. Ellis Scientific Reports.2023;[Epub] CrossRef
Recent progress in vaccine development targeting pre-clinical human toxoplasmosis Ki-Back Chu, Fu-Shi Quan Parasites, Hosts and Diseases.2023; 61(3): 231. CrossRef
Protective immunity induced by CpG ODN‐adjuvanted virus‐like particles containing Toxoplasma gondii proteins Hae‐Ji Kang, Ki‐Back Chu, Min‐Ju Kim, Su‐Hwa Lee, Hyunwoo Park, Hui Jin, Eun‐Kyung Moon, Fu‐Shi Quan Parasite Immunology.2021;[Epub] CrossRef
Protective Immunity Against Neospora caninum Infection Induced by 14-3-3 Protein in Mice Shan Li, Nan Zhang, Shaoxiong Liu, Jianhua Li, Li Liu, Xiaocen Wang, Xin Li, Pengtao Gong, Xichen Zhang Frontiers in Veterinary Science.2021;[Epub] CrossRef
Toxoplasma gondii virus‐like particle vaccination alleviates inflammatory response in the brain upon T gondii infection Hae‐Ji Kang, Ki‐Back Chu, Su‐Hwa Lee, Min‐Ju Kim, Hyunwoo Park, Hui Jin, Eun‐Kyung Moon, Fu‐Shi Quan Parasite Immunology.2020;[Epub] CrossRef
Evaluation of CpG-ODN-Adjuvanted Toxoplasma gondii Virus-Like Particle Vaccine upon One, Two, and Three Immunizations Hae-Ji Kang, Ki-Back Chu, Min-Ju Kim, Hyunwoo Park, Hui Jin, Su-Hwa Lee, Eun-Kyung Moon, Fu-Shi Quan Pharmaceutics.2020; 12(10): 989. CrossRef
Human infections due to the monkey malaria parasite Plasmodium knowlesi is increasingly being reported from most Southeast Asian countries specifically Malaysia. The parasite causes severe and fatal malaria thus there is a need for urgent measures for its control. In this study, the level of polymorphisms, haplotypes and natural selection of full-length pkmsp8 in 37 clinical samples from Malaysian Borneo along with 6 lab-adapted strains were investigated. Low levels of polymorphism were observed across the full-length gene, the double epidermal growth factor (EGF) domains were mostly conserved, and non-synonymous substitutions were absent. Evidence of strong negative selection pressure in the non-EGF regions were found indicating functional constrains acting at different domains. Phylogenetic haplotype network analysis identified shared haplotypes and indicated geographical clustering of samples originating from Peninsular Malaysia and Malaysian Borneo. This is the first study to genetically characterize the full-length msp8 gene from clinical isolates of P. knowlesi from Malaysia; however, further functional characterization would be useful for future rational vaccine design.
Citations
Citations to this article as recorded by
Plasmodium knowlesi: the game changer for malaria eradication Wenn-Chyau Lee, Fei Wen Cheong, Amirah Amir, Meng Yee Lai, Jia Hui Tan, Wei Kit Phang, Shahhaziq Shahari, Yee-Ling Lau Malaria Journal.2022;[Epub] CrossRef
Both Plasmodium spp. and Toxoplasma gondii are important apicomplexan parasites, which infect humans worldwide. Genetic analyses have revealed that 33% of amino acid sequences of inner membrane complex from the malaria parasite Plasmodium berghei is similar to that of Toxoplasma gondii. Inner membrane complex is known to be involved in cell invasion and replication. In this study, we investigated the resistance against T. gondii (ME49) infection induced by previously infected P. berghei (ANKA) in mice. Levels of T. gondii-specific IgG, IgG1, IgG2a, and IgG2b antibody responses, CD4+ and CD8+ T cell populations were found higher in the mice infected with P. berghei (ANKA) and challenged with T. gondii (ME49) compared to that in control mice infected with T. gondii alone (ME49). P. berghei (ANKA) + T. gondii (ME49) group showed significantly reduced the number and size of T. gondii (ME49) cysts in the brains of mice, resulting in lower body weight loss compared to ME49 control group. These results indicate that previous exposure to P. berghei (ANKA) induce resistance to subsequent T. gondii (ME49) infection.
Citations
Citations to this article as recorded by
Functionality of Toxoplasma gondii antibodies in a population of Beninese pregnant women exposed to malaria Mariama Souffou, Célia Dechavanne, Zaineb Kammoun, Firmine Viwami, Isabelle Gaugué, Naima Beldjoudi, Sébastien Dechavanne, Nawal Sare, André Garcia, Magalie Dambrun, Florence Migot-Nabias Scientific Reports.2025;[Epub] CrossRef
Neuroprotective and antimalarial effects of Juglans regia leaf extracts in a murine model of cerebral malaria Afra Alharbi, Shurug Albasyouni, Esam Al-Shaebi, Saleh Al Quraishy, Rewaida Abdel-Gaber Frontiers in Veterinary Science.2025;[Epub] CrossRef
Protective mucosal and systemic immunity induced by virus-like particles expressing Toxoplasma gondii cyst wall protein Gi-Deok Eom, Ki-Back Chu, Hae-Ji Kang, Min-Ju Kim, Keon-Woong Yoon, Jie Mao, Su-Hwa Lee, Md Atique Ahmed, Eun-Kyung Moon, Fu-Shi Quan, Paulo Lee Ho PLOS ONE.2023; 18(4): e0283928. CrossRef
Monocyte-Derived Chicken Macrophages Exposed to Eimeria tenella Sporozoites Display Reduced Susceptibility to Invasion by Toxoplasma gondii Tachyzoite Runhui Zhang, Wanpeng Zheng, Arwid Daugschies, Berit Bangoura Microorganisms.2023; 11(8): 1999. CrossRef
Retrospective study of toxoplasmosis prevalence in pregnant women in Benin and its relation with malaria Magalie Dambrun, Célia Dechavanne, Nicolas Guigue, Valérie Briand, Tristan Candau, Nadine Fievet, Murielle Lohezic, Saraniya Manoharan, Nawal Sare, Firmine Viwami, François Simon, Sandrine Houzé, Florence Migot-Nabias, Gordon Langsley PLOS ONE.2022; 17(1): e0262018. CrossRef
Toxoplasma gondii is a ubiquitous protozoan parasite responsible for causing toxoplasmosis. Preventive measures for toxoplasmosis are currently lacking and as such, development of novel vaccines are of urgent need. In this study, we generated 2 virus-like particles (VLPs) vaccines expressing T. gondii rhoptry protein 4 (ROP4) or rhoptry protein 18 (ROP18) using influenza matrix protein (M1) as a core protein. Mice were intranasally immunized with VLPs vaccines and after the last immunization, mice were challenged with ME49 cysts. Protective efficacy was assessed and compared by determining serum antibody responses, body weight changes and the reduction of cyst counts in the brain. ROP18 VLPs-immunized mice induced greater levels of IgG and IgA antibody responses than those immunized with ROP4 VLPs. ROP18 VLPs immunization significantly reduced body weight loss and the number of brain cysts in mice compared to ROP4 VLPs post-challenge. These results indicate that T. gondii ROP18 VLPs elicited better protective efficacy than ROP4 VLPs, providing important insight into vaccine design strategy.
Citations
Citations to this article as recorded by
Evaluation of a DNA vector plasmid encoding a partial rop18 gene from toxoplasma gondii in domestic cats as a vaccine candidate Ana Flávia Minutti, João Pedro Sasse, Ana Clécia dos Santos Silva, Thais Agostinho Martins, Valentina Martinez, Beatriz de Souza Lima Nino, Fernando de Souza Rodrigues, Luiz Daniel de Barros, João Luis Garcia Vaccine.2025; 54: 126965. CrossRef
Applications of virus-like particles in the prevention of protozoan parasite infection Ki Back Chu, Fu-Shi Quan Nanomedicine.2025; 20(13): 1573. CrossRef
Recent progress in vaccine development targeting pre-clinical human toxoplasmosis Ki-Back Chu, Fu-Shi Quan Parasites, Hosts and Diseases.2023; 61(3): 231. CrossRef
Orally Administrated Recombinant Vaccinia Virus Displaying ROP4 Induces Protection against Toxoplasma gondii Challenge Infection Keon-Woong Yoon, Ki-Back Chu, Hae-Ji Kang, Min-Ju Kim, Gi-Deok Eom, Fu-Shi Quan Vaccines.2022; 10(2): 152. CrossRef
Protective immunity induced by CpG ODN‐adjuvanted virus‐like particles containing Toxoplasma gondii proteins Hae‐Ji Kang, Ki‐Back Chu, Min‐Ju Kim, Su‐Hwa Lee, Hyunwoo Park, Hui Jin, Eun‐Kyung Moon, Fu‐Shi Quan Parasite Immunology.2021;[Epub] CrossRef
A peptide originated from Toxoplasma gondii microneme 8 displaying serological evidence to differentiate recent from chronic human infection Silas Silva Santana, Vinícius Fernandes Paiva, Fernando Reis Carvalho, Heber Leão Silva Barros, Tamires Lopes Silva, Patrício Silva Cardoso Barros, Ana Cláudia Arantes Marquez Pajuaba, Geisa Baptista Barros, Reynaldo Dietze, Tiago Wilson Patriarca Mineo, Parasitology International.2021; 84: 102394. CrossRef
Evaluation of CpG-ODN-Adjuvanted Toxoplasma gondii Virus-Like Particle Vaccine upon One, Two, and Three Immunizations Hae-Ji Kang, Ki-Back Chu, Min-Ju Kim, Hyunwoo Park, Hui Jin, Su-Hwa Lee, Eun-Kyung Moon, Fu-Shi Quan Pharmaceutics.2020; 12(10): 989. CrossRef
Previous Infection with Plasmodium berghei Confers Resistance to Toxoplasma gondii Infection in Mice Dong-Hun Lee, Ki-Back Chu, Hae-Ji Kang, Su-Hwa Lee, Fu-Shi Quan The Korean Journal of Parasitology.2019; 57(2): 93. CrossRef
Influenza Virus-Like Particles Presenting both Toxoplasma gondii ROP4 and ROP13 Enhance Protection against T. gondii Infection Hae-Ji Kang, Su-Hwa Lee, Min-Ju Kim, Ki-Back Chu, Dong-Hun Lee, Manika Chopra, Hyo-Jick Choi, Hyunwoo Park, Hui Jin, Fu-Shi Quan Pharmaceutics.2019; 11(7): 342. CrossRef
Virus-like particles containing multiple antigenic proteins of Toxoplasma gondii induce memory T cell and B cell responses Su-Hwa Lee, Ki-Back Chu, Hae-Ji Kang, Fu-Shi Quan, Paulo Lee Ho PLOS ONE.2019; 14(8): e0220865. CrossRef
First
Prev
